E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/31/2006 in the Prospect News Biotech Daily.

New Issue: Viragen raises $17.42 million in sale of 67 million units at $0.26 each

By Ronda Fears

Memphis, Oct. 31 - Viragen, Inc. raised $17.42 million from the sale of 67 million units at $0.26 each via underwriter Dawson James Securities, Inc. Each unit consists of one share of common stock and a warrant to purchase one share of common stock at a strike price of $0.31.

Viragen common shares (Amex: VRA) closed Monday at $0.32.

The units will trade on the American Stock Exchange under the ticker "VRA.U." The warrants will become exercisable on the date of separation from the unit, which will be April 30, 2007, or earlier if so determined by the underwriter, and will expire on Oct. 29, 2011.

In addition to the offering and greenshoe, Viragen said it also has agreed to sell to the underwriter, Dawson James, for $100, an option to buy up to 4.02 million units identical to those offered publicly except that the exercise price per unit is $0.29, and per warrant underlying such unit is $0.39.

Plantation, Fla.-based Viragen concentrates on cancers and viral diseases. Its product candidates are Multiferon for malignant melanoma, VG101 for malignant melanoma tumors and VG102 for solid tumors. The company also is developing the OVA System with the renowned Roslin Institute, creators of cloned sheep Dolly, as a revolutionary manufacturing platform for the large-scale, efficient and economical production of human therapeutic proteins and antibodies, by expressing these products in the egg whites of transgenic hens.

Proceeds are earmarked to redeem preferred shares, to make interest payments on debt, for research and sales activities, for working capital and for general corporate purposes.

Issuer:Viragen, Inc.
Issue:Units of one common share and one warrant to purchase one common share
Gross proceeds:$17.42 million
Net proceeds:$16.37 million
Units:67 million
Greenshoe:10.05 million units
Price:$0.26 per unit
Warrants:One warrant per unit
Warrant strike price:$0.31
Warrant expiration:Oct. 29, 2011
Bookrunner:Dawson James Securities, Inc.
Pricing date:Oct. 30
Settlement date:Nov. 3
Stock symbol:Amex: VRA
Stock price:$0.32 on Oct. 30

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.